Outcomes of patients with acute myeloid leukemia who relapse after 5 years of complete remission
نویسندگان
چکیده
منابع مشابه
Prognostic factors and outcomes of adult patients with acute myeloid leukemia after first relapse.
BACKGROUND Patients with acute myeloid leukemia who are treated with conventional chemotherapy still have a substantial risk of relapse; the prognostic factors and optimal treatments after relapse have not been fully established. We, therefore, retrospectively analyzed data from patients with acute myeloid leukemia who had achieved first complete remission to assess their prognosis after first ...
متن کاملMolecular remission in chronic myeloid leukemia patients with sustained complete cytogenetic remission after imatinib mesylate treatment.
BACKGROUND AND OBJECTIVES Imatinib mesylate induces a complete cytogenetic response (CCR) in many patients with chronic myeloid leukemia (CML). However, the ultimate goal of therapy for CML is complete elimination of Philadelphia chromosome positive cells or BCR-ABL rearrangements. We studied molecular responses in CML patients in CCR after imatinib treatment. DESIGN AND METHODS Real-time qua...
متن کاملRelapse and death during first remission in acute myeloid leukemia.
Many papers have discussed the advisability of administering intensive chemotherapy to older patients with untreated acute myeloid leukemia (AML). More specifically, several studies have attempted to identify patients at particularly high risk of induction death following such therapy. However, the issue of chemotherapy-induced death once patients are in complete remission (CR) has received les...
متن کاملSingle-agent lenalidomide induces complete remission of acute myeloid leukemia in patients with isolated trisomy 13.
Patients with acute myeloid leukemia (AML) frequently fail chemotherapy due to refractory disease, relapse, or toxicity. Among older AML patients (age > 60 years), there are few long-term survivors. Lenalidomide is a candidate for study in AML based on its clinical activity in a related disorder, myelodysplastic syndrome (MDS), with the 5q- chromosomal abnormality. We report induction of sustai...
متن کاملEstimating leukemia-free survival after allografting for chronic myeloid leukemia: a new method that takes into account patients who relapse and are restored to complete remission.
A significant number of patients who relapse after allogeneic stem cell transplantation (SCT) for chronic myeloid leukemia (CML) will achieve sustained remissions after treatment with interferon-alpha, second transplants, or donor lymphocyte infusions (DLI) from the original stem cell donor. Because leukemia-free survival (LFS) is at present defined as survival without evidence of relapse at an...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
سال: 2020
ISSN: 0965-0407
DOI: 10.3727/096504020x15965357399750